Twist Bioscience Corp (TWST)

90.40 +2.66  +3.03% NASDAQ Dec 8, 16:00 90.40 0.00  0.00% After-Hours: 20:00 USD

Twist Bioscience Cash from Financing (TTM):

329.18M for Sept. 30, 2021
View 4,000+ financial data types
View Full Chart

Cash from Financing (TTM) Chart

Export Data
Save Image
Print Image

Historical Cash from Financing (TTM) Data

View and export this data going back to 2018. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2021 329.18M
June 30, 2021 333.18M
March 31, 2021 442.01M
Dec. 31, 2020 628.60M
Sept. 30, 2020 303.73M
June 30, 2020 301.09M
March 31, 2020 277.31M
Dec. 31, 2019 87.64M
Sept. 30, 2019 158.58M
June 30, 2019 162.23M
March 31, 2019 102.78M
Dec. 31, 2018 159.16M
Sept. 30, 2018 88.82M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.


Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Benchmarks

Becton, Dickinson and Co -3.306B
Xtant Medical Holdings Inc 16.81M
Asensus Surgical Inc 169.08M

Cash from Financing (TTM) Range, Past 5 Years

Minimum 87.64M Dec 2019
Maximum 628.60M Dec 2020
Average 259.56M


Insider Sell: Twist Bioscience
MT Newswires 12/06 17:38 ET
Insider Sell: Twist Bioscience
MT Newswires 11/23 17:14 ET
Company News for Nov 23, 2021
Yahoo 11/23 09:31 ET
Sector Update: Health Care
MT Newswires 11/22 08:56 ET



Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.